These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 2509120)

  • 1. Erythrocyte sedimentation rate and heterotopic bone formation after cemented total hip arthroplasty.
    Kjaersgaard-Andersen P; Schmidt SA; Pedersen NW; Kristensen SS; Pedersen P
    Clin Orthop Relat Res; 1989 Nov; (248):189-94. PubMed ID: 2509120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alkaline phosphatase as an indicator of heterotopic bone formation following total hip arthroplasty.
    Kjaersgaard-Andersen P; Pedersen P; Kristensen SS; Schmidt SA; Pedersen NW
    Clin Orthop Relat Res; 1988 Sep; (234):102-9. PubMed ID: 3136963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of heterotopic ossification by radiotherapy following total hip prosthesis].
    Alberti W; Quack G; Krischke W; Lommatzsch A; Huyer C; Krahl H
    Dtsch Med Wochenschr; 1995 Jul; 120(28-29):983-9. PubMed ID: 7621742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty.
    Shih LY; Wu JJ; Yang DJ
    Clin Orthop Relat Res; 1987 Dec; (225):238-46. PubMed ID: 3677512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of aspirin to prevent heterotopic ossification after total hip arthroplasty. A preliminary report.
    Freiberg AA; Cantor R; Freiberg RA
    Clin Orthop Relat Res; 1991 Jun; (267):93-6. PubMed ID: 1904336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short term prophylaxis against heterotopic bone after cementless hip replacement.
    Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R
    Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.
    Pohl F; Seufert J; Tauscher A; Lehmann H; Springorum HW; Flentje M; Koelbl O
    Strahlenther Onkol; 2005 Aug; 181(8):529-33. PubMed ID: 16044221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
    Schara K; Herman S
    Acta Chir Orthop Traumatol Cech; 2001; 68(2):105-8. PubMed ID: 11706718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
    Kjaersgaard-Andersen P; Schmidt SA
    Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in erythrocyte sedimentation rate and C-reactive protein after total hip arthroplasty.
    Aalto K; Osterman K; Peltola H; Räsänen J
    Clin Orthop Relat Res; 1984 Apr; (184):118-20. PubMed ID: 6705332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
    van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
    Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty.
    Fingeroth RJ; Ahmed AQ
    Clin Orthop Relat Res; 1995 Aug; (317):131-40. PubMed ID: 7671467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
    Grohs JG; Schmidt M; Wanivenhaus A
    Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors affecting the development of para-articular ossification in total hip replacement].
    Landor I; Vavrík P; Havelka S; Jahoda D
    Acta Chir Orthop Traumatol Cech; 1993; 60(2):76-80. PubMed ID: 8342379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
    Gebuhr P; Wilbek H; Soelberg M
    Clin Orthop Relat Res; 1995 May; (314):166-9. PubMed ID: 7634631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indomethacin in the prevention of para-articular ossification following total hip endoprosthesis].
    Hochheim B; Wünsche F
    Beitr Orthop Traumatol; 1990 Jun; 37(6):330-4. PubMed ID: 2117436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of indomethacin on para-articular ectopic ossification following total hip arthroplasty.
    Ritter MA; Gioe TJ
    Clin Orthop Relat Res; 1982 Jul; (167):113-7. PubMed ID: 6807593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial.
    Schmidt SA; Kjaersgaard-Andersen P; Pedersen NW; Kristensen SS; Pedersen P; Nielsen JB
    J Bone Joint Surg Am; 1988 Jul; 70(6):834-8. PubMed ID: 3134359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketorolac prophylaxis against heterotopic ossification after hip replacement.
    Pritchett JW
    Clin Orthop Relat Res; 1995 May; (314):162-5. PubMed ID: 7634630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative radiotherapy in the prevention of heterotopic ossification after endoprosthetic hip joint replacement].
    Heyd R; Strassmann G; Kirchner J; Schopohl B; Böttcher HD
    Strahlenther Onkol; 1996 Oct; 172(10):543-52. PubMed ID: 8966671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.